ConductScience.org, home

Paper2970871

Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.

Pui CH and 9 others. Blood, 1988. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. Papers, record 2970871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2970871

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.
PubMed
Journal
Blood
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2022-04-09
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pui CHC H
2Ip SHS H
3Dodge RKR K
4Carrabis SS
5Brown MM
6Crist WMW M
7Berard CWC W
8Kung PP
9Dahl GVG V
10Murphy SBS B

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, Differentiation, T-LymphocyteMajor topic
Biomarkers, TumorMajor topic
Leukemia, LymphoidMajor topic
Lymphoma, Non-HodgkinMajor topic
T-Lymphocytes, RegulatoryMajor topic
Adolescent
Adult
Animals
Antibodies, Monoclonal
Antigens, Surface
CD8 Antigens
Child
Child, Preschool
Female
Humans
Infant
Male
Mice
Mice, Inbred BALB C
Prognosis
Risk Factors

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA-20180NCI NIH HHSUnited StatesP01CA020180PubMed and NIHNIH RePORTER
CA-21765NCI NIH HHSUnited StatesP30CA021765PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
36688998Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.Cancer Immunol Immunother2023https://conductscience.org/library/papers/36688998PubMed
31440093iTRAQ-based quantitative protein expression profiling of biomarkers in childhood B-cell and T-cell acute lymphoblastic leukemia.Cancer Manag Res2019https://conductscience.org/library/papers/31440093PubMed
8740979Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.Urol Res1996https://conductscience.org/library/papers/8740979PubMed
8306503High serum levels of soluble CD8 in insulin-dependent diabetes.Clin Exp Immunol1994https://conductscience.org/library/papers/8306503PubMed
8124911Soluble CD4 and CD8 molecules in patients with systemic sclerosis.Clin Rheumatol1993https://conductscience.org/library/papers/8124911PubMed
2523899Decreased production of CD8 (T8) antigen after immunotherapy.J Clin Immunol1989https://conductscience.org/library/papers/2523899PubMed
2332021Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors.Eur J Pediatr1990https://conductscience.org/library/papers/2332021PubMed
1934593Raised serum levels of CD8, CD25 and beta 2-microglobulin in common variable immunodeficiency.Clin Exp Immunol1991https://conductscience.org/library/papers/1934593PubMed
1903673Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with non-resectable lung cancer.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1903673PubMed
1878895Lymphocyte activation in patients with acute myeloid leukaemia. Evidence for the presence of myeloblast antigen?Cancer Immunol Immunother1991https://conductscience.org/library/papers/1878895PubMed
1833097High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction?Clin Exp Immunol1991https://conductscience.org/library/papers/1833097PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2970871

GET https://conductscience.org/api/papers/v1/2970871/authors